Eli Lilly Acquires QurAlis’ UNC13A-Targeting Compounds for Neurodegenerative Diseases
Eli Lilly and Company (NYSE: LLY) has announced the acquisition of global development and commercialization...
Eli Lilly and Company (NYSE: LLY) has announced the acquisition of global development and commercialization...